Barriers to patient access of CAR T cell therapies in Austria

Georg Hopfinger; B Rupp; Richard Greil

doi:10.1007/s12254-022-00859-w

Barriers to patient access of CAR T cell therapies in Austria

Georg Hopfinger (First author), B Rupp, Richard Greil^* (Last author)

^*Corresponding author for this work

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

5 Citations (Web of Science)

Original language	English
Journal	memo - Magazine of European Medical Oncology
DOIs	https://doi.org/10.1007/s12254-022-00859-w
Publication status	Published - 2023

Keywords

LYMPHOMA
TRANSPLANTATION
MANAGEMENT
STANDARD
OUTCOMES

Access to Document

10.1007/s12254-022-00859-w

Cite this

@article{b457188622054aa4831ccf6d06834bcd,

title = "Barriers to patient access of CAR T cell therapies in Austria",

keywords = "LYMPHOMA, TRANSPLANTATION, MANAGEMENT, STANDARD, OUTCOMES",

author = "Georg Hopfinger and B Rupp and Richard Greil",

note = "Greil: Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute—Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Cancer Cluster Salzburg, Paracelsus Medical University, 5020, Salzburg, Austria",

year = "2023",

doi = "10.1007/s12254-022-00859-w",

language = "English",

journal = "memo - Magazine of European Medical Oncology",

issn = "1865-5041",

publisher = "Springer Verlag",

}

TY - JOUR

T1 - Barriers to patient access of CAR T cell therapies in Austria

AU - Hopfinger, Georg

AU - Rupp, B

AU - Greil, Richard

N1 - Greil: Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute—Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Cancer Cluster Salzburg, Paracelsus Medical University, 5020, Salzburg, Austria

PY - 2023

Y1 - 2023

KW - LYMPHOMA

KW - TRANSPLANTATION

KW - MANAGEMENT

KW - STANDARD

KW - OUTCOMES

U2 - 10.1007/s12254-022-00859-w

DO - 10.1007/s12254-022-00859-w

M3 - Original Article

SN - 1865-5041

JO - memo - Magazine of European Medical Oncology

JF - memo - Magazine of European Medical Oncology

ER -